Berlin Researchers Identify New Signaling Pathway as Potential Breakthrough in Chronic Inflammatory Bowel Disease Treatment
Chronic inflammatory bowel diseases (IBD) remain among the most challenging conditions in modern gastroenterology, characterized by their persistent nature, debilitating symptoms, and the long-term risk of severe complications, including colorectal cancer. For many patients, the diagnosis marks the beginning of a lifelong struggle with an overactive immune system that mistakenly attacks the gastrointestinal tract. However, […]
